Stay informed about the latest diabetes news and research, including medical discoveries, treatment developments, clinical studies, technology and emerging health insights.
Philadelphia-based Century Therapeutics remains on track to file an IND for CNTY-813 by late 2026, showing promising preclinical results in immune-evasive cell therapy for type 1 diabetes as it prepares for clinical trials and upcoming presentations. Century Therapeutics said it…
Emerging research highlights Neuregulin 4 as a key link between fat tissue and metabolic regulation, but inconsistent human data and safety concerns temper clinical optimism. Future studies are needed to clarify its role and therapeutic potential. Neuregulin 4 is emerging…
A Laidlaw research placement at Nexus and the Cheney Biomedical Accelerator has provided a student with new perspectives on metabolic disease, highlighting the importance of interdisciplinary tools like flow cytometry, high-throughput imaging, and protein analysis in understanding insulin resistance and…
New research employing advanced imaging techniques finds that changes in both outer and inner bone structures contribute to higher fracture risks in older adults with type 2 diabetes, challenging reliance on bone density alone for risk assessment. A new study…
FibroBiologics has obtained a US patent aimed at improving pancreatic islet transplantation, marking a significant scientific milestone in its developing cell-based therapies for Type 1 diabetes amid broader research in regenerative medicine. FibroBiologics has taken another step in building out…
FibroBiologics has been granted a US patent for a novel method leveraging fibroblasts to improve the survival and function of transplanted pancreatic islets, boosting prospects for advanced type 1 diabetes therapies and beyond. FibroBiologics said it has been granted a…
Prime Minister Mostafa Madbouly inaugurates a new family medicine centre in Sendbast as part of Egypt’s rural development programme, expanding healthcare access for over 47,000 residents and strengthening the nation’s push towards universal health coverage. At the start of his…
The UK has approved Foundayo, the first oral weight-loss treatment in Europe, providing a potential alternative for those avoiding injectable therapies, pending NHS funding approval. The UK has become the first country in Europe to approve a new oral weight-loss…
Meitheal Pharmaceuticals has gained FDA approval for GARZULYS, a rapid-acting insulin biosimilar, intensifying competition in a market historically dominated by originator products and few biosimilar entries. Meitheal Pharmaceuticals said on July 30, 2026 that the U.S. Food and Drug Administration…
Eli Lilly’s shares rose nearly 4% after the UK’s MHRA approved Foundayo, its first weight-loss pill, marking a key milestone in the competitive obesity treatment market and granting the company a European foothold. Eli Lilly’s shares climbed nearly 4% on…
Egypt’s Health Ministry has responded to criticism over insulin imports, emphasising local manufacturing capabilities and distinguishing between brand shortages and overall drug availability to reassure diabetic patients amid ongoing debates on medicine imports. Egypt’s Health Ministry has moved to calm…
Egypt’s health authorities highlight a strategic shift towards local insulin production, aiming to reduce reliance on imports and secure medicines for its burgeoning diabetic population, with plans to expand exports across Africa. Egypt’s health minister has said the country’s insulin…
